Patients with respiratory symptoms and disease deserve a correct diagnosis and correct guideline driven care that is standardized, patient focused, delivered by a Health Care Professional (HCP) with suitable training and experience, at a site and within an appropriate timeframe to meet their need

NICE has published new indicators for asthma and COPD, part of a suite of new indicators, which will inform negotiations for the 2020/21 QOF in England.

Management of Chronic Respiratory Conditions for Primary and Community Practitioners Continuing Professional Development (short course) Cambridge 12 weeks Module level: 6 and 7 Module credits: 30 credits  

NICE has published an updated COPD guideline which makes recommendations on inhaled triple therapy, and oral corticosteroids for managing exacerbations.

Point-of-care testing of C-reactive protein (CRP) in primary care may help reduce unnecessary prescribing of antibiotics for people with COPD, according to new research published in the New England Journal of Medicine (NEJM).

Please note an error has been corrected in the PCRS treatment guidelines article "All that glitters is not GOLD, nor is it even NICE" which first appeared in the Spring 2019 issue of Primary Care Respiratory Update.

A comprehensive geriatric assessment and a holistic approach in primary care is key to reducing the impact of frailty and co-morbidities in older patients with COPD.

Briefing document for National Respiratory Strategies – the NHS Long term plan and Lung Health Taskforce 5 year plan.

People with COPD feel independent and enjoy support from family and friends with good access to amenities when healthcare and social support works well, reports a study which investigated  what matters to people wit

A consensus-based article setting out a practical approach to conflicting advice in recent COPD guidance updates has been published by PCRS.

An integrated disease management (IDM) and structured follow up intervention reduces severe exacerbations and urgent primary care visits in people with high risk COPD.